Rheumatologic manifestations in myelodysplastic syndrome.

作者: Daniel A. Albert , Christopher M. Burns

DOI: 10.1097/RHU.0B013E31825003E4

关键词:

摘要:

参考文章(21)
Jeffrey J. Molldrem, Yin Zheng Jiang, Maryalice Stetler-Stevenson, Dimitrios Mavroudis, Nancy Hensel, A. John Barrett, Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. British Journal of Haematology. ,vol. 102, pp. 1314- 1322 ,(1998) , 10.1046/J.1365-2141.1998.00920.X
A. M. Marcondes, A. J. Mhyre, D. L. Stirewalt, S.-H. Kim, C. A. Dinarello, H. J. Deeg, Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 2865- 2870 ,(2008) , 10.1073/PNAS.0712391105
S Giannouli, D Tzoanopoulos, K Ritis, G Kartalis, HM Moutsopoulos, M Voulgarelis, Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression Annals of the Rheumatic Diseases. ,vol. 63, pp. 578- 582 ,(2004) , 10.1136/ARD.2003.012948
Richard C. Chou, Charles A. Dinarello, Judith A. Ferry, Paola Dal Cin, A 36-year-old woman with recurrent high-grade fevers, hypotension, and hypertriglyceridemia Arthritis Care and Research. ,vol. 62, pp. 128- 136 ,(2010) , 10.1002/ACR.20024
Elaine M. Sloand, Loretta Pfannes, Gubin Chen, Simant Shah, Elena E. Solomou, John Barrett, Neal S. Young, CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins. Blood. ,vol. 109, pp. 2399- 2405 ,(2007) , 10.1182/BLOOD-2006-01-030643
M. Voulgarelis, S. Giannouli, K. Ritis, A. G. Tzioufas, Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts. European Journal of Clinical Investigation. ,vol. 34, pp. 690- 700 ,(2004) , 10.1111/J.1365-2362.2004.01417.X
Elaine M. Sloand, Lori Mainwaring, Monika Fuhrer, Shakti Ramkissoon, Antonio M. Risitano, Keyvan Keyvanafar, Jun Lu, Atanu Basu, A. John Barrett, Neal S. Young, Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood. ,vol. 106, pp. 841- 851 ,(2005) , 10.1182/BLOOD-2004-05-2017
Seth J. Corey, Mark D. Minden, Dwayne L. Barber, Hagop Kantarjian, Jean C. Y. Wang, Aaron D. Schimmer, Myelodysplastic syndromes: the complexity of stem-cell diseases Nature Reviews Cancer. ,vol. 7, pp. 118- 129 ,(2007) , 10.1038/NRC2047
Shahram Y. Kordasti, Behdad Afzali, Ziyi Lim, Wendy Ingram, Janet Hayden, Linda Barber, Katie Matthews, Rajani Chelliah, Barbara Guinn, Giovanna Lombardi, Farzin Farzaneh, Ghulam J. Mufti, IL-17-producing CD4(+) T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome. British Journal of Haematology. ,vol. 145, pp. 64- 72 ,(2009) , 10.1111/J.1365-2141.2009.07593.X
S S Strom, Y Gu, S K Gruschkus, S A Pierce, E H Estey, Risk factors of myelodysplastic syndromes: a case-control study. Leukemia. ,vol. 19, pp. 1912- 1918 ,(2005) , 10.1038/SJ.LEU.2403945